Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To evaluate the efficacy and safety of electroconductive (EC) and electrohydraulic (EH) extracorporeal shock wave lithotripsy (ESWL) for the treatment of ureter and kidney stones, this study conducted a randomized controlled trial.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Electroconductive Type | Other | Sonolith i-move® shockwave lithotripter (EDAP, Lyon, France) |
|
| Electrohydraulic Type | Other | Rifle lithotripter (HNT Medical, Seoul, Korea) |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Electroconductive and Electrohydraulic types | Device | The patients were randomly assigned to two types of lithotripter. |
|
| Measure | Description | Time Frame |
|---|---|---|
| age | patient's records | 2 weeks |
| Gender | patient's records | 2 weeks |
| height | meters | 2 weeks |
| weight | kilograms | 2 weeks |
| smoking | patient's records | 2 weeks |
| drinking | patient's records | 2 weeks |
| Diabetes mellitus | patient's records | 2 weeks |
| Hypertension | patient's records | 2 weeks |
| Preoperative Double J stent | patient's records | 2 weeks |
| creatinine | patient's records |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Seoul National University Hospital | Seoul | 110-744 | South Korea |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 35801399 | Background | Motolova M, Kral M. Effect of targeting and generator type on efficacy of extracorporeal shock wave lithotripsy. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2022 Dec;166(4):434-440. doi: 10.5507/bp.2022.029. Epub 2022 Jun 27. |
Not provided
Not provided
The datasets used during the current study are available from the corresponding author on request.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D052878 | Urolithiasis |
| ID | Term |
|---|---|
| D014570 | Urologic Diseases |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 2 weeks |
| Glomerular Filtration Rate | patient's records | 2 weeks |
| hemoglobin | patient's records | 2 weeks |
| Hydronephrosis grade |
| 2 weeks |
| Analgesic | patient's records | 2 weeks |
| stone size | patient's records | 2 weeks |
| Stone laterality | patient's records | 2 weeks |
| Stone location | patient's records | 2 weeks |
| Stone volume | patient's records | 2 weeks |
| Stone shape | patient's records | 2 weeks |
| Stone to skin distance | patient's records | 2 weeks |
| Hounsfield unit | patient's records | 2 weeks |
| Urine color | patient's records | 2 weeks |
| Urine Turbidity | patient's records | 2 weeks |
| Urine Specific Gravity | patient's records | 2 weeks |
| Urine pH | patient's records | 2 weeks |
| Intensity | ESWL | 2 weeks |
| Used power | ESWL | 2 weeks |
| Shock | ESWL | 2 weeks |
| Speed | ESWL | 2 weeks |
| Visual analog scale for pain | 0: Represents "No sensation" or "Not at all." 1-3: Indicates a very mild sensation or a low level of the experience, signifying almost no problem. 4-6: Represents a moderate level, suggesting a moderate presence of the experience or issue. 7-9: Reflects a high or severe level, signifying a significant presence or seriousness of the problem. 10: Represents "Maximal sensation" or "Extremely intense" and indicates an extreme presence or severity of the experience or issue. | 2 weeks |
| Satisfaction score |
| 2 weeks |
| Stone-free rates (%) | ESWL | 2 weeks |
| D052801 | Male Urogenital Diseases |